{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Authors: Phu Dang and Diane Dinh\n",
    "\n",
    "Purpose: Pedal ROI Data Analysis\n",
    "\n",
    "Date: 05.11.2023\n",
    "\n",
    "Number of projects per investment pillar (AG-AK) (Phu & Diane) \\\n",
    "Name of project title and clinical trials(DA-DG) (Phu & Diane) \\\n",
    "Number of peer-reviewed publications (DM) (Phu & Diane) \\\n",
    "Name of project titles that will lead to improvements in health policy (FD, FL) (Phu & Diane)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Importing libraries and packages\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np \n",
    "import matplotlib.pyplot as plt \n",
    "import seaborn as sns\n",
    "import plotly.express as px\n",
    "import os\n",
    "\n",
    "# pd.set_option('display.max_rows', None)\n",
    "# Adjust dataframe display options to view full output\n",
    "pd.set_option('display.max_columns', None)\n",
    "pd.set_option('display.width', None)\n",
    "\n",
    "# Reset to default ~ comment 2 lines above and \n",
    "# uncomment 2 lines below, run all before pushing to GitHub\n",
    "# pd.set_option('display.max_columns', 20)\n",
    "# pd.set_option('display.width', 80)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Read datasets\n",
    "\n",
    "os.chdir('../data')\n",
    "fp = os.path.join('interim', '2022_Pedal_Progress_Report.csv').replace(\"\\\\\",\"/\")\n",
    "pr = pd.read_csv(fp, index_col=0)\n",
    "\n",
    "fp = os.path.join('interim', '2022_Pedal_ROI.csv').replace(\"\\\\\",\"/\")\n",
    "roi = pd.read_csv(fp, index_col=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Fourth DOI #</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Fifth DOI #</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Sixth DOI #</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Seventh DOI #</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Eighth DOI #</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Ninth DOI #</th>\n",
       "      <th>Publication Status 10</th>\n",
       "      <th>Tenth DOI #</th>\n",
       "      <th>Pedal Non-Peer Pubs</th>\n",
       "      <th>Other Accomplishments</th>\n",
       "      <th>Health Benefits</th>\n",
       "      <th>International</th>\n",
       "      <th>National</th>\n",
       "      <th>Local</th>\n",
       "      <th>General Public</th>\n",
       "      <th>Healthcare Professionals</th>\n",
       "      <th>Patients</th>\n",
       "      <th>Patient Families</th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Equity Benefits</th>\n",
       "      <th>International (equity)</th>\n",
       "      <th>National (equity)</th>\n",
       "      <th>Local (equity)</th>\n",
       "      <th>General Public (equity)</th>\n",
       "      <th>Healthcare Professionals (equity)</th>\n",
       "      <th>Patients (equity)</th>\n",
       "      <th>Patient Families (equity)</th>\n",
       "      <th>Equity Benefits Description</th>\n",
       "      <th>Additional Funding Achieved</th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Name and Project Title</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Name and Project Title</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Name and Project Title</th>\n",
       "      <th>Third AGS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Name and Project Title</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Additional Funding Source #5 Agency/Sponsor Name and Project Title</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Additional Pedal Funding Impact</th>\n",
       "      <th>Additional Funding Benefits Description</th>\n",
       "      <th>Additional Pedal Funding Impact (clinical stages)</th>\n",
       "      <th>Additional Funding Benefits Description (clinical stages)</th>\n",
       "      <th>Participated in Pedal</th>\n",
       "      <th>Further Research Contributions</th>\n",
       "      <th>Success Stories</th>\n",
       "      <th>Major Scientific Breakthroughs</th>\n",
       "      <th>Additional Comments</th>\n",
       "      <th>Complete</th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>First DOI #</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Second DOI #</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Third DOI #</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIH R35HG011315 Using genomic perturbations to...</td>\n",
       "      <td>1500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding would enable the applicatio...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>In addition, funding could allow us to do more...</td>\n",
       "      <td>Yes, I have participated as a rider every year...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adam K. Fuhs S, Meisenhelder J,  Lesperan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>the Hartwell Foundation</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Pediatric Cancer Research Foundation</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R03CA273629-01</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Tower Cancer Research Foundation</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>500000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None to date</td>\n",
       "      <td>additional funding provided by Padres Pedal th...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of cabozantinib with 13-cis-re...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Exelixis, Inc.</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to e...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>See above in the progress report.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Oral cancer prevention and the consequent redu...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>At risk oral cancer patients are often part of...</td>\n",
       "      <td>One</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R01, will likely be funded soon</td>\n",
       "      <td>2500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>For advancing the planned clinical trial and c...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Identification of biomarkers predicting clinic...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Many thanks for all your support!!!</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...</td>\n",
       "      <td>2019-present Member, Wnt Signaling in Prostate...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Trial focused on all demographic of prostate c...</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>377000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This is a grass roots project. It is a single ...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, runner.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    ID          Event Name Publication Status 4 Fourth DOI #  \\\n",
       "0  3.0  Progress Report #1                  NaN          NaN   \n",
       "1  4.0  Progress Report #1                  NaN          NaN   \n",
       "2  5.0  Progress Report #1                  NaN          NaN   \n",
       "3  6.0  Progress Report #1                  NaN          NaN   \n",
       "4  8.0  Progress Report #1                  NaN          NaN   \n",
       "\n",
       "  Publication Status 5 Fifth DOI # Publication Status 6 Sixth DOI #  \\\n",
       "0                  NaN         NaN                  NaN         NaN   \n",
       "1                  NaN         NaN                  NaN         NaN   \n",
       "2                  NaN         NaN                  NaN         NaN   \n",
       "3                  NaN         NaN                  NaN         NaN   \n",
       "4                  NaN         NaN                  NaN         NaN   \n",
       "\n",
       "  Publication Status 7 Seventh DOI # Publication Status 8 Eighth DOI #  \\\n",
       "0                  NaN           NaN                  NaN          NaN   \n",
       "1                  NaN           NaN                  NaN          NaN   \n",
       "2                  NaN           NaN                  NaN          NaN   \n",
       "3                  NaN           NaN                  NaN          NaN   \n",
       "4                  NaN           NaN                  NaN          NaN   \n",
       "\n",
       "  Publication Status 9 Ninth DOI # Publication Status 10 Tenth DOI #  \\\n",
       "0                  NaN         NaN                   NaN         NaN   \n",
       "1                  NaN         NaN                   NaN         NaN   \n",
       "2                  NaN         NaN                   NaN         NaN   \n",
       "3                  NaN         NaN                   NaN         NaN   \n",
       "4                  NaN         NaN                   NaN         NaN   \n",
       "\n",
       "                                 Pedal Non-Peer Pubs  \\\n",
       "0                                                NaN   \n",
       "1       Adam K. Fuhs S, Meisenhelder J,  Lesperan...   \n",
       "2                                       None to date   \n",
       "3                                                NaN   \n",
       "4  8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...   \n",
       "\n",
       "                               Other Accomplishments Health Benefits  \\\n",
       "0                                                NaN             Yes   \n",
       "1                                                NaN             Yes   \n",
       "2  additional funding provided by Padres Pedal th...             Yes   \n",
       "3                  See above in the progress report.             Yes   \n",
       "4  2019-present Member, Wnt Signaling in Prostate...             Yes   \n",
       "\n",
       "   International  National  Local  General Public  Healthcare Professionals  \\\n",
       "0          False     False  False           False                     False   \n",
       "1           True     False  False           False                     False   \n",
       "2           True     False  False           False                     False   \n",
       "3           True      True  False           False                     False   \n",
       "4          False     False  False           False                     False   \n",
       "\n",
       "   Patients  Patient Families Policy Influence  International (pol)  \\\n",
       "0      True             False               No                False   \n",
       "1     False             False               No                False   \n",
       "2     False             False               No                False   \n",
       "3      True              True               No                False   \n",
       "4      True             False               No                False   \n",
       "\n",
       "   National (pol)  Local (pol)  General Public (pol)  \\\n",
       "0           False        False                 False   \n",
       "1           False        False                 False   \n",
       "2           False        False                 False   \n",
       "3           False        False                 False   \n",
       "4           False        False                 False   \n",
       "\n",
       "   Healthcare Professionals (pol)  Patients (pol)  Patient Families (pol)  \\\n",
       "0                           False           False                   False   \n",
       "1                           False           False                   False   \n",
       "2                           False           False                   False   \n",
       "3                           False           False                   False   \n",
       "4                           False           False                   False   \n",
       "\n",
       "  Policy Benefits Description Economic Benefits  International (econ)  \\\n",
       "0                         NaN                No                 False   \n",
       "1                         NaN                No                 False   \n",
       "2                         NaN               Yes                 False   \n",
       "3                         NaN               Yes                  True   \n",
       "4                         NaN                No                 False   \n",
       "\n",
       "   National (econ)  Local (econ)  General Public (econ)  \\\n",
       "0            False         False                  False   \n",
       "1            False         False                  False   \n",
       "2             True         False                  False   \n",
       "3             True         False                  False   \n",
       "4            False         False                  False   \n",
       "\n",
       "   Healthcare Professionals (econ)  Patients (econ)  Patient Families (econ)  \\\n",
       "0                            False            False                    False   \n",
       "1                            False            False                    False   \n",
       "2                            False            False                    False   \n",
       "3                            False             True                     True   \n",
       "4                            False            False                    False   \n",
       "\n",
       "                       Economic Benefits Description Equity Benefits  \\\n",
       "0                                                NaN              No   \n",
       "1                                                NaN              No   \n",
       "2  The combination of cabozantinib with 13-cis-re...              No   \n",
       "3  Oral cancer prevention and the consequent redu...             Yes   \n",
       "4                                                NaN             Yes   \n",
       "\n",
       "   International (equity)  National (equity)  Local (equity)  \\\n",
       "0                   False              False           False   \n",
       "1                   False              False           False   \n",
       "2                   False              False           False   \n",
       "3                    True               True           False   \n",
       "4                   False              False           False   \n",
       "\n",
       "   General Public (equity)  Healthcare Professionals (equity)  \\\n",
       "0                    False                              False   \n",
       "1                    False                              False   \n",
       "2                    False                              False   \n",
       "3                    False                              False   \n",
       "4                    False                              False   \n",
       "\n",
       "   Patients (equity)  Patient Families (equity)  \\\n",
       "0              False                      False   \n",
       "1              False                      False   \n",
       "2              False                      False   \n",
       "3               True                       True   \n",
       "4               True                      False   \n",
       "\n",
       "                         Equity Benefits Description  \\\n",
       "0                                                NaN   \n",
       "1                                                NaN   \n",
       "2                                                NaN   \n",
       "3  At risk oral cancer patients are often part of...   \n",
       "4  Trial focused on all demographic of prostate c...   \n",
       "\n",
       "  Additional Funding Achieved First AFS Status  \\\n",
       "0                         One          Awarded   \n",
       "1                        Five          Awarded   \n",
       "2                         One          Awarded   \n",
       "3                         One        Submitted   \n",
       "4                         One          Awarded   \n",
       "\n",
       "                    First AFS Name and Project Title  First AFS Amount  \\\n",
       "0  NIH R35HG011315 Using genomic perturbations to...         1500000.0   \n",
       "1                            the Hartwell Foundation          300000.0   \n",
       "2                                     Exelixis, Inc.          250000.0   \n",
       "3                NIH R01, will likely be funded soon         2500000.0   \n",
       "4                                         Oncternal           377000.0   \n",
       "\n",
       "  Second AFS Status Second AFS Name and Project Title  Second AFS Amount  \\\n",
       "0               NaN                               NaN                NaN   \n",
       "1           Awarded            Padres Pedal the Cause           100000.0   \n",
       "2               NaN                               NaN                NaN   \n",
       "3               NaN                               NaN                NaN   \n",
       "4               NaN                               NaN                NaN   \n",
       "\n",
       "  Third AFS Status      Third AFS Name and Project Title  Third AGS Amount  \\\n",
       "0              NaN                                   NaN               NaN   \n",
       "1        Submitted  Pediatric Cancer Research Foundation          750000.0   \n",
       "2              NaN                                   NaN               NaN   \n",
       "3              NaN                                   NaN               NaN   \n",
       "4              NaN                                   NaN               NaN   \n",
       "\n",
       "  Fourth AFS Status Fourth AFS Name and Project Title  Fourth AFS Amount  \\\n",
       "0               NaN                               NaN                NaN   \n",
       "1         Submitted                NIH R03CA273629-01           150000.0   \n",
       "2               NaN                               NaN                NaN   \n",
       "3               NaN                               NaN                NaN   \n",
       "4               NaN                               NaN                NaN   \n",
       "\n",
       "  Additional Funding Source #5 Agency/Sponsor Name and Project Title  \\\n",
       "0                                                NaN                   \n",
       "1                   Tower Cancer Research Foundation                   \n",
       "2                                                NaN                   \n",
       "3                                                NaN                   \n",
       "4                                                NaN                   \n",
       "\n",
       "  Fifth AFS Status  Fifth AFS Amount Additional Pedal Funding Impact  \\\n",
       "0              NaN               NaN                             Yes   \n",
       "1        Submitted          500000.0                             Yes   \n",
       "2              NaN               NaN                             Yes   \n",
       "3              NaN               NaN                             Yes   \n",
       "4              NaN               NaN                             Yes   \n",
       "\n",
       "             Additional Funding Benefits Description  \\\n",
       "0  Additional funding would enable the applicatio...   \n",
       "1  Additional funding support would allow us to p...   \n",
       "2  Additional funding support would allow us to e...   \n",
       "3  For advancing the planned clinical trial and c...   \n",
       "4  This is a grass roots project. It is a single ...   \n",
       "\n",
       "  Additional Pedal Funding Impact (clinical stages)  \\\n",
       "0                                               Yes   \n",
       "1                                               Yes   \n",
       "2                                               Yes   \n",
       "3                                               Yes   \n",
       "4                                                No   \n",
       "\n",
       "  Additional Funding Benefits Description (clinical stages)  \\\n",
       "0  In addition, funding could allow us to do more...          \n",
       "1  Additional funding support would allow us to p...          \n",
       "2  Additional funding support would allow us to p...          \n",
       "3  Identification of biomarkers predicting clinic...          \n",
       "4                                                NaN          \n",
       "\n",
       "                               Participated in Pedal  \\\n",
       "0  Yes, I have participated as a rider every year...   \n",
       "1  I have participated as both a virtual particip...   \n",
       "2  I have participated as both a virtual particip...   \n",
       "3                                                Yes   \n",
       "4                                      Yes, runner.    \n",
       "\n",
       "  Further Research Contributions Success Stories  \\\n",
       "0                             No              No   \n",
       "1                            Yes              No   \n",
       "2                            Yes             Yes   \n",
       "3                             No              No   \n",
       "4                            Yes              No   \n",
       "\n",
       "  Major Scientific Breakthroughs  \\\n",
       "0                            NaN   \n",
       "1                            NaN   \n",
       "2                            Yes   \n",
       "3                            NaN   \n",
       "4                            NaN   \n",
       "\n",
       "                                 Additional Comments  Complete  \\\n",
       "0                                                NaN      True   \n",
       "1  Funding from Padres Pedal the Cause has been i...      True   \n",
       "2  Funding from Padres Pedal the Cause has been i...      True   \n",
       "3                Many thanks for all your support!!!      True   \n",
       "4                                                NaN      True   \n",
       "\n",
       "  Publication Status 1 First DOI # Publication Status 2 Second DOI #  \\\n",
       "0             Accepted         NaN                  NaN          NaN   \n",
       "1             Accepted         NaN            Submitted          NaN   \n",
       "2            Published         NaN                  NaN          NaN   \n",
       "3          In progress         NaN          In progress          NaN   \n",
       "4                  NaN         NaN                  NaN          NaN   \n",
       "\n",
       "  Publication Status 3 Third DOI #  \n",
       "0                  NaN         NaN  \n",
       "1                  NaN         NaN  \n",
       "2                  NaN         NaN  \n",
       "3                  NaN         NaN  \n",
       "4                  NaN         NaN  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>3.1</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify genes that are dysregulated in neurob...</td>\n",
       "      <td>Identify and characterize de novo germline and...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Improved knowledge of the genetic mutations th...</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2021-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The PPTC funding allowed a postdoctoral resear...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No Trials</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>4.1</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Evaluate the functional role of NME1 expressio...</td>\n",
       "      <td>Evaluate the functional role of NME1 histidine...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with aggressive neuroblastoma have po...</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2020-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No Trials</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>5.1</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the safety, dose-limiting toxicities...</td>\n",
       "      <td>Identify biomarkers predictive of patient resp...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with high-risk and recurrent solid tu...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2023-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One Trial</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.1</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding our un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Opportunity to develop an immune modulatory ap...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One Trial</td>\n",
       "      <td>Metformin for oral cancer prevention 2.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>8.1</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To investigate the safety and tolerability of ...</td>\n",
       "      <td>To evaluate the anti-tumor activity of cirmtuz...</td>\n",
       "      <td>To prospectively interrogate the Wnt signaling...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Metastatic castration resistant prostate cance...</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>2020-01-01</td>\n",
       "      <td>2021-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes this grant was supporting the infrastructu...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One Trial</td>\n",
       "      <td>Phase 1B, Nonrandomized Trial Investigating Do...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    ID Event Name  Award ID  \\\n",
       "0  3.0    Initial       3.1   \n",
       "2  4.0    Initial       4.1   \n",
       "4  5.0    Initial       5.1   \n",
       "6  6.0    Initial       6.1   \n",
       "8  8.0    Initial       8.1   \n",
       "\n",
       "                                       Project Title        PI Institution  \\\n",
       "0  Detecting dysregulated genes in neuroblastoma ...        Salk Institute   \n",
       "2  Functional Roles for Histidine Kinase Signalin...       Rady Children's   \n",
       "4  A National Phase I Study of Cabozantinib in Co...       Rady Children's   \n",
       "6  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "8  A Phase 1B, Nonrandomized Trial Investigating ...  Moores Cancer Center   \n",
       "\n",
       "  Other Institution  Prevention and diagnostic tools  \\\n",
       "0               NaN                            False   \n",
       "2               NaN                            False   \n",
       "4               NaN                            False   \n",
       "6               NaN                            False   \n",
       "8               NaN                            False   \n",
       "\n",
       "   Novel approaches and new therapeutic platforms  \\\n",
       "0                                           False   \n",
       "2                                           False   \n",
       "4                                           False   \n",
       "6                                           False   \n",
       "8                                            True   \n",
       "\n",
       "   Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                      False                          False   \n",
       "2                                      False                          False   \n",
       "4                                      False                          False   \n",
       "6                                      False                          False   \n",
       "8                                      False                          False   \n",
       "\n",
       "   Pediatric cancers        Specific Aims  \\\n",
       "0               True    Two Specific Aims   \n",
       "2               True    Two Specific Aims   \n",
       "4               True    Two Specific Aims   \n",
       "6              False  Three Specific Aims   \n",
       "8              False  Three Specific Aims   \n",
       "\n",
       "                                               Aim 1  \\\n",
       "0  Identify genes that are dysregulated in neurob...   \n",
       "2  Evaluate the functional role of NME1 expressio...   \n",
       "4  Determine the safety, dose-limiting toxicities...   \n",
       "6  Improve outcomes for HNSCC by expanding our un...   \n",
       "8  To investigate the safety and tolerability of ...   \n",
       "\n",
       "                                               Aim 2  \\\n",
       "0  Identify and characterize de novo germline and...   \n",
       "2  Evaluate the functional role of NME1 histidine...   \n",
       "4  Identify biomarkers predictive of patient resp...   \n",
       "6  Leverage our administrative, biostatistics, co...   \n",
       "8  To evaluate the anti-tumor activity of cirmtuz...   \n",
       "\n",
       "                                               Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0                                                NaN   NaN   NaN   NaN   \n",
       "2                                                NaN   NaN   NaN   NaN   \n",
       "4                                                NaN   NaN   NaN   NaN   \n",
       "6  Develop emerging, novel, high quality translat...   NaN   NaN   NaN   \n",
       "8  To prospectively interrogate the Wnt signaling...   NaN   NaN   NaN   \n",
       "\n",
       "                          Public Health Significance  Award Amount  \\\n",
       "0  Improved knowledge of the genetic mutations th...      100000.0   \n",
       "2  Children with aggressive neuroblastoma have po...      100000.0   \n",
       "4  Children with high-risk and recurrent solid tu...      200000.0   \n",
       "6  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "8  Metastatic castration resistant prostate cance...      150000.0   \n",
       "\n",
       "  Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "0        2019-07-15      2021-07-14  Complete      True   \n",
       "2        2019-07-15      2020-07-14  Complete     False   \n",
       "4        2021-07-01      2023-06-30  Complete     False   \n",
       "6        2021-07-01      2022-06-30  Complete     False   \n",
       "8        2020-01-01      2021-12-31  Complete     False   \n",
       "\n",
       "  SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                   False                                 False   \n",
       "2                   False                                 False   \n",
       "4                   False                                 False   \n",
       "6                   False                                  True   \n",
       "8                   False                                  True   \n",
       "\n",
       "  SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                  False                           False   \n",
       "2                   True                           False   \n",
       "4                   True                           False   \n",
       "6                  False                            True   \n",
       "8                   True                            True   \n",
       "\n",
       "  SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                   False                                  False   \n",
       "2                   False                                  False   \n",
       "4                   False                                  False   \n",
       "6                   False                                   True   \n",
       "8                   False                                   True   \n",
       "\n",
       "  SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                    False               False                       False   \n",
       "2                    False               False                       False   \n",
       "4                    False               False                       False   \n",
       "6                    False               False                       False   \n",
       "8                    False               False                       False   \n",
       "\n",
       "  SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                     False                                    False   \n",
       "2                     False                                    False   \n",
       "4                     False                                    False   \n",
       "6                     False                                    False   \n",
       "8                     False                                    False   \n",
       "\n",
       "  SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                False                                  False   \n",
       "2                False                                  False   \n",
       "4                False                                  False   \n",
       "6                False                                  False   \n",
       "8                False                                  False   \n",
       "\n",
       "  SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                  False                           False   \n",
       "2                                   True                           False   \n",
       "4                                  False                           False   \n",
       "6                                  False                           False   \n",
       "8                                  False                           False   \n",
       "\n",
       "  Cancer Metabolism SBPMDI  \\\n",
       "0                    False   \n",
       "2                    False   \n",
       "4                    False   \n",
       "6                    False   \n",
       "8                    False   \n",
       "\n",
       "  Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                Yes       \n",
       "2                                                Yes       \n",
       "4                                                Yes       \n",
       "6                                                Yes       \n",
       "8                                                Yes       \n",
       "\n",
       "                              If yes, please specify If no, please specify  \\\n",
       "0  The PPTC funding allowed a postdoctoral resear...                   NaN   \n",
       "2  The availability of funding from Padres Pedal ...                   NaN   \n",
       "4  The availability of funding from Padres Pedal ...                   NaN   \n",
       "6  Opportunity to develop an immune modulatory ap...                   NaN   \n",
       "8  Yes this grant was supporting the infrastructu...                   NaN   \n",
       "\n",
       "  Clinical Trials Resulted                               First Clinical Trial  \\\n",
       "0                No Trials                                                NaN   \n",
       "2                No Trials                                                NaN   \n",
       "4                One Trial  A National Phase I Study of Cabozantinib in Co...   \n",
       "6                One Trial           Metformin for oral cancer prevention 2.0   \n",
       "8                One Trial  Phase 1B, Nonrandomized Trial Investigating Do...   \n",
       "\n",
       "   First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "0                                 NaN                   NaN   \n",
       "2                                 NaN                   NaN   \n",
       "4                                 6.0                   NaN   \n",
       "6                                80.0                   NaN   \n",
       "8                                 0.0                   NaN   \n",
       "\n",
       "   Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "0                                  NaN              None            No   \n",
       "2                                  NaN              none            No   \n",
       "4                                  NaN              None            No   \n",
       "6                                  NaN                No            No   \n",
       "8                                  NaN         Oncternal            No   \n",
       "\n",
       "  Patent Details Peer-Reviewed Publications Count  \n",
       "0            NaN                              One  \n",
       "2            NaN                              Two  \n",
       "4            NaN                              One  \n",
       "6            NaN                              Two  \n",
       "8            NaN                             Zero  "
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "five_pillars = ['Prevention and diagnostic tools', \n",
    "                'Novel approaches and new therapeutic platforms',\n",
    "                'Immunotherapies and personalized vaccines',\n",
    "                'Addressing cancer disparities',\n",
    "                'Pediatric cancers']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "190\n",
      "False    153\n",
      "True      37\n",
      "Name: Prevention and diagnostic tools, dtype: int64\n",
      "\n",
      "190\n",
      "False    123\n",
      "True      67\n",
      "Name: Novel approaches and new therapeutic platforms, dtype: int64\n",
      "\n",
      "190\n",
      "False    154\n",
      "True      36\n",
      "Name: Immunotherapies and personalized vaccines, dtype: int64\n",
      "\n",
      "190\n",
      "False    187\n",
      "True       3\n",
      "Name: Addressing cancer disparities, dtype: int64\n",
      "\n",
      "190\n",
      "False    143\n",
      "True      47\n",
      "Name: Pediatric cancers, dtype: int64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for col in five_pillars:\n",
    "    print(roi[col].value_counts().sum())\n",
    "    print(roi[col].value_counts())\n",
    "    print()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Prevention and diagnostic tools                   0\n",
       "Novel approaches and new therapeutic platforms    0\n",
       "Immunotherapies and personalized vaccines         0\n",
       "Addressing cancer disparities                     0\n",
       "Pediatric cancers                                 0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[five_pillars].isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "190\n",
      "190\n"
     ]
    }
   ],
   "source": [
    "print(len(roi['ID'].unique()))\n",
    "print(roi.shape[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.2"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
